1171892-42-4

Basic information

• Product Name: 5-Isopropoxypyridine-3-boronic acid pinacol ester
• Synonyms: 5-Isopropoxypyridine-3-boronic acid pinacol ester;5-isopropoxypyridin-3-ylboronic acid pinacol ester;3-propan-2-yloxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
• CAS NO: 1171892-42-4
• Molecular Formula: C14H24BNO4
• Molecular Weight: 281.15566
• Mol File: 1171892-42-4.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-Isopropoxypyridine-3-boronic acid pinacol ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Isopropoxypyridine-3-boronic acid pinacol ester(1171892-42-4)
• EPA Substance Registry System: 5-Isopropoxypyridine-3-boronic acid pinacol ester(1171892-42-4)

Safety Data

• Hazardous Substances Data: 1171892-42-4(Hazardous Substances Data)

Usage

General Description

5-Isopropoxypyridine-3-boronic acid pinacol ester is a chemical compound with the molecular formula C13H19BN2O3. It is a boronic acid ester derivative and is commonly used in organic synthesis and medicinal chemistry as a building block for the synthesis of various pharmaceuticals and agrochemicals. The compound is known for its ability to act as a reagent in Suzuki-Miyaura cross-coupling reactions to form carbon-carbon bonds, making it a valuable tool in the creation of complex organic molecules. Its unique structure and reactivity make it a versatile and important compound in the field of organic chemistry.

Upstream product

• 73183-34-3 bis(pinacol)diborane 
• 212332-40-6 3-bromo-5-isopropoxypyridine 

Relevant articles and documents

PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS

The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular ltk activity.

1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The invention relates to the use of 1 H-imidazo[4,5-c]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1 H-imidazo[4,5-c]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1 H-imidazo[4,5-c]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1 H-imidazo[4,5-c]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H-imidazo[4,5-c]quinolinone compounds; and a process for the preparation of the novel 1 H-imidazo[4,5-c]quinolinone compounds.